#gskplc — Public Fediverse posts

Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era?

On July 28, GSK plc (NYSE:GSK) reported its second-quarter financial results, delivering strong core operational performance and showcasing…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #PhaseIIItrial
https://www.europesays.com/britain/103070/

https://www.europesays.com/britain/103070/ Could GSK plc (GSK)’s Pipeline Acceleration Unlock a New Growth Era? #GSK #GSKPlc #PhaseIIITrial

GSK plc reports 13F portfolio of 13 holdings | GSK SEC Filing

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined…
#EuropeSays #Britain #Europe #EU #GSK #13Fholdingsreport #602220442totalvalue #GSKplc #institutionalinvestmentmanager #SECfiling #SECForm13F #USequityportfolio
https://www.europesays.com/britain/103040/

https://www.europesays.com/britain/103040/ GSK plc reports 13F portfolio of 13 holdings | GSK SEC Filing #13FHoldingsReport #602220442TotalValue #GSK #GSKPlc #InstitutionalInvestmentManager #SECFiling #SECForm13F #USEquityPortfolio

GSK executives acquire shares via reward plan | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #InsiderTransactions #JulieBrown #LondonStockExchange #LynnBaxter #ordinaryshares #sharerewardplan
https://www.europesays.com/britain/102909/

https://www.europesays.com/britain/102909/ GSK executives acquire shares via reward plan | GSK SEC Filing #GSK #GSKPlc #InsiderTransactions #JulieBrown #LondonStockExchange #LynnBaxter #OrdinaryShares #ShareRewardPlan

GSK executive acquires notional ADS in savings plan | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #ADSacquisition #AmericanDepositaryShares #executivesupplementalsavingsplan #Form6-K #GSKplc #insidertransaction
https://www.europesays.com/britain/101397/

https://www.europesays.com/britain/101397/ GSK executive acquires notional ADS in savings plan | GSK SEC Filing #ADSAcquisition #AmericanDepositaryShares #ExecutiveSupplementalSavingsPlan #Form6K #GSK #GSKPlc #InsiderTransaction

GSK updates total voting rights for July 2026 | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE…
#EuropeSays #Britain #Europe #EU #GSK #DisclosureGuidanceandTransparencyRules #Form6-K #GSKplc #ordinaryshares #sharecapital #shareholdernotifications #totalvotingrights #treasuryshares #UKlisting
https://www.europesays.com/britain/99948/

https://www.europesays.com/britain/99948/ GSK updates total voting rights for July 2026 | GSK SEC Filing #DisclosureGuidanceAndTransparencyRules #Form6K #GSK #GSKPlc #OrdinaryShares #ShareCapital #ShareholderNotifications #TotalVotingRights #TreasuryShares #UKListing

GSK hits three-month high as vaccines help earnings top forecasts

GSK hits three-month high as vaccines help earnings top forecasts Proactive uses images sourced from Shutterstock GSK PLC…
#EuropeSays #Britain #Europe #EU #GSK #earningspershare #GSKplc #respiratorysyncytialvirus #Vaccines
https://www.europesays.com/britain/98728/

https://www.europesays.com/britain/98728/ GSK hits three-month high as vaccines help earnings top forecasts #EarningsPerShare #GSK #GSKPlc #RespiratorySyncytialVirus #Vaccines

https://www.europesays.com/britain/97431/ AstraZeneca and Bristol Myers Squibb mull $400 billion deal: Report #AstraZeneca #AstraZenecaPLC #BiotechAndPharmaceuticals #BristolMyersSquibbCo #Business #BusinessNews #GileadSciencesInc #GSKPlc #HealthCareIndustry #InvescoPharmaceuticalsETF #ISharesUSPharmaceuticalsETF #MergersAndAcquisitions #PfizerInc #Pharmaceuticals #SpdrS&PBiotechEtf #SpdrS&PPharmaceuticalsEtf #UnitedStates

GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline …

This article first appeared on GuruFocus. Revenue: Q2 sales up 5% to more than GBP8.4 billion. Core Operating…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Q2sales
https://www.europesays.com/britain/93411/

https://www.europesays.com/britain/93411/ GSK PLC (GSK) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Accelerated Pipeline … #GSK #GSKPlc #Q2Sales

GSK Beats Second-Quarter Forecasts and Unveils £1.9 Billion Efficiency Programme

GSK ©Adobe Stock Images GSK Plc (LSE:GSK) reported stronger-than-expected second-quarter results on Tuesday, driven by continued momentum in…
#EuropeSays #Britain #Europe #EU #GSK #clinicaldevelopment #GSKplc #restructuringcosts #Vaccines
https://www.europesays.com/britain/92505/

https://www.europesays.com/britain/92505/ GSK Beats Second-Quarter Forecasts and Unveils £1.9 Billion Efficiency Programme #ClinicalDevelopment #GSK #GSKPlc #RestructuringCosts #Vaccines

https://www.europesays.com/britain/92377/ GSK Q2 2026: core profits rise, EPS hit by charges | GSK SEC Filing #AccelerateGrowthProgramme #CamlipixantImpairment #CoreEPS505p #FreeCashFlow #GSK #GSK2026Q2Results #GSKPlc #Pharmaceuticals #QuarterlyEarnings

GSK to build new £400m Cambridge R&D centre | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #biopharmaresearch #CambridgeBiomedicalCampus #Form6-K #GSKplc #Stevenagesite #UKR&Dinvestment #Warelaboratories
https://www.europesays.com/britain/92346/

https://www.europesays.com/britain/92346/ GSK to build new £400m Cambridge R&D centre | GSK SEC Filing #BiopharmaResearch #CambridgeBiomedicalCampus #Form6K #GSK #GSKPlc #StevenageSite #UKR&DInvestment #WareLaboratories

GSK admits 70,759 new shares to London market | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #admissiontotrading #blocklisting #Form6-K #GSKplc #LondonStockExchange #ordinaryshares #ShareSavePlan2022
https://www.europesays.com/britain/89766/

https://www.europesays.com/britain/89766/ GSK admits 70,759 new shares to London market | GSK SEC Filing #AdmissionToTrading #BlockListing #Form6K #GSK #GSKPlc #LondonStockExchange #OrdinaryShares #ShareSavePlan2022

GSK executive acquires 9.4 notional ADS in plan | GSK SEC Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 6-K   REPORT OF FOREIGN PRIVATE ISSUER…
#EuropeSays #Britain #Europe #EU #GSK #ADS #AmericanDepositaryShares #executivesupplementalsavingsplan #Form6-K #GSKplc #insidertransaction #MayaMartinez-Davis #NYSE
https://www.europesays.com/britain/89735/

https://www.europesays.com/britain/89735/ GSK executive acquires 9.4 notional ADS in plan | GSK SEC Filing #ADS #AmericanDepositaryShares #ExecutiveSupplementalSavingsPlan #Form6K #GSK #GSKPlc #InsiderTransaction #MayaMartinezDavis #NYSE

GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC

GSK plc GSK announced that the FDA has approved Jideytro (zidesamtinib) for previously treated ROS1-positive non-small cell lung…
#EuropeSays #Britain #Europe #EU #GSK #FDA #GSKplc #Jideytro #NeurocrineBiosciences #non-smallcelllungcancer #ZacksInvestmentResearch #ZacksRank
https://www.europesays.com/britain/88972/

https://www.europesays.com/britain/88972/ GSK Lands FDA Approval for Nuvalent-Acquired Jideytro for NSCLC #FDA #GSK #GSKPlc #Jideytro #NeurocrineBiosciences #NonSmallCellLungCancer #ZacksInvestmentResearch #ZacksRank

Will GSK’s Specialty Medicines Boost Q2 Revenue Growth?

GSK plc’s GSK Specialty Medicines business segment spans four core areas: Respiratory, Immunology & Inflammation (RI&I), Oncology and…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #GSKstock #Oncology #Oncologysales #patientdemand #specialty #ZacksInvestmentResearch
https://www.europesays.com/britain/88940/

https://www.europesays.com/britain/88940/ Will GSK’s Specialty Medicines Boost Q2 Revenue Growth? #GSK #GSKPlc #GSKStock #Oncology #OncologySales #PatientDemand #specialty #ZacksInvestmentResearch

Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer

Approval based on ARROS-1 phase I/II trial demonstrating meaningful and durable responses in patients with locally advanced or…
#EuropeSays #Britain #Europe #EU #GSK #Biotechnology #ClinicalTrials&MedicalDiscoveries #FDAapproval #GSKplc #HealthCare&Hospitals #MedicalEquipment #MedicalPharmaceuticals #Pharmaceuticals
https://www.europesays.com/britain/88598/

https://www.europesays.com/britain/88598/ Jideytro (zidesamtinib) approved in the US for previously treated ROS1-positive non-small cell lung cancer #Biotechnology #ClinicalTrials&MedicalDiscoveries #FDAApproval #GSK #GSKPlc #HealthCare&Hospitals #MedicalEquipment #MedicalPharmaceuticals #Pharmaceuticals

Eli Lilly makes a new push into vaccines – here’s what to know

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike…
#NewsBeep #News #Healthcare #AU #Australia #BiotechandPharmaceuticals #businessnews #EliLillyandCo #GSKplc #Health #Healthcareindustry #ModernaInc #RobertF.KennedyJr. #Socialissues
https://www.newsbeep.com/au/698169/

Is Britain back? Five things to watch for the U.K. in 2026

This report is from this week’s CNBC’s UK Exchange newsletter. Like what you see? You can subscribe here. …
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Economy #BPPLC #British10YearGilt #Business #businessnews #China #CristianoAmon #DiageoPLC #donaldtrump #Economicevents #FTSE100 #GBP/USD #GSKplc #KeirStarmer #PerellaWeinbergPartners #SevernTrentPLC #ToyotaMotorCorp. #WalterIsaacson
https://www.newsbeep.com/us/393030/

Markets could face ‘everything bubble’ as selloff rages on

Global stocks have fluctuated wildly over the past week, as concerns abou…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Artificialintelligence #AI #AlphabetClassA #ArtificialIntelligence #businessnews #GSKplc #Investmentstrategy #Markets #MetaPlatformsInc #MicrosoftCorp #NewYork #NovoNordiskA/S #NVIDIACorp #regwall-pro #RocheHoldingAG #Stockmarkets #Technology #TeslaInc #WorldMarkets
https://www.newsbeep.com/us/310462/

Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

https://web.brid.gy/r/https://www.nytimes.com/2025/09/26/business/europe-pharma-tariffs-trump.html

Wary European Drugmakers Think They Can Avoid Trump’s Latest Tariffs

https://web.brid.gy/r/https://www.nytimes.com/2025/09/26/business/europe-pharma-tariffs-trump.html